Roberto Bitton

655 total citations
10 papers, 556 citations indexed

About

Roberto Bitton is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Roberto Bitton has authored 10 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Roberto Bitton's work include Immunotherapy and Immune Responses (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Cancer Research and Treatments (2 papers). Roberto Bitton is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Cancer Research and Treatments (2 papers). Roberto Bitton collaborates with scholars based in United States, Argentina and Cuba. Roberto Bitton's co-authors include Rodney C. Schnur, Len Neckers, Christine Chavany, Jane B. Trepel, James D. Moyer, Luke Whitesell, Edward G. Mimnaugh, Ana María Vázquez, Marcelo D. Guthmann and Leonardo Fainboim and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Roberto Bitton

9 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Bitton United States 9 427 235 107 96 68 10 556
Maya Datt Joshi United States 9 479 1.1× 143 0.6× 179 1.7× 116 1.2× 67 1.0× 14 644
Zahide Özer United States 14 265 0.6× 196 0.8× 135 1.3× 37 0.4× 59 0.9× 23 583
Marie-Christine Multon France 11 441 1.0× 68 0.3× 138 1.3× 66 0.7× 101 1.5× 14 667
Joël S. Bloch Switzerland 11 307 0.7× 104 0.4× 184 1.7× 46 0.5× 41 0.6× 18 531
Mizue Inoue Japan 16 501 1.2× 336 1.4× 114 1.1× 139 1.4× 79 1.2× 31 705
A. Takada Japan 8 494 1.2× 225 1.0× 131 1.2× 157 1.6× 91 1.3× 19 758
Shashi Mehta United States 11 224 0.5× 329 1.4× 147 1.4× 82 0.9× 37 0.5× 32 619
Sheila Zrihan‐Licht Israel 11 457 1.1× 169 0.7× 137 1.3× 193 2.0× 92 1.4× 12 577
Olga Lubman United States 11 355 0.8× 77 0.3× 85 0.8× 28 0.3× 42 0.6× 11 517
Toshihide Nishibata Japan 6 362 0.8× 75 0.3× 161 1.5× 63 0.7× 53 0.8× 8 492

Countries citing papers authored by Roberto Bitton

Since Specialization
Citations

This map shows the geographic impact of Roberto Bitton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Bitton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Bitton more than expected).

Fields of papers citing papers by Roberto Bitton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Bitton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Bitton. The network helps show where Roberto Bitton may publish in the future.

Co-authorship network of co-authors of Roberto Bitton

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Bitton. A scholar is included among the top collaborators of Roberto Bitton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Bitton. Roberto Bitton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bitton, Roberto, et al.. (2007). LEUCEMIA MIELOIDE CRONICA MECANISMOS GENETICOS DE RESISTENCIA AL IMATINIB. Medicina-buenos Aires. 67. 71–74.
2.
Guthmann, Marcelo D., M. Castro, Gabriela Cinat, et al.. (2006). Cellular and Humoral Immune Response to N-Glycolyl-GM3 Elicited by Prolonged Immunotherapy With an Anti-Idiotypic Vaccine in High-Risk and Metastatic Breast Cancer Patients. Journal of Immunotherapy. 29(2). 215–223. 50 indexed citations
3.
Guthmann, Marcelo D., Roberto Bitton, Mariano R. Gabri, et al.. (2004). Active Specific Immunotherapy of Melanoma with a GM3 Ganglioside-Based Vaccine. Journal of Immunotherapy. 27(6). 442–451. 34 indexed citations
4.
Bitton, Roberto. (2004). Cancer vaccines: a critical review on clinical impact.. PubMed. 6(1). 17–26. 12 indexed citations
5.
Bitton, Roberto, Marcelo D. Guthmann, Mariano R. Gabri, et al.. (2002). Cancer vaccines: An update with special focus on ganglioside antigens (Review). Oncology Reports. 9(2). 267–76. 55 indexed citations
6.
Alfonso, Mauro, Ana Hernández, Alexis Perez‐Gonzalez, et al.. (2002). An Anti-Idiotype Vaccine Elicits a Specific Response to N-Glycolyl Sialic Acid Residues of Glycoconjugates in Melanoma Patients. The Journal of Immunology. 168(5). 2523–2529. 97 indexed citations
7.
Chavany, Christine, Edward G. Mimnaugh, Roberto Bitton, et al.. (1996). p185erbB2 Binds to GRP94 in Vivo. Journal of Biological Chemistry. 271(9). 4974–4977. 226 indexed citations
8.
Figg, William D., Nancy A. Dawson, Oliver Sartor, et al.. (1996). A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response. Cancer Chemotherapy and Pharmacology. 39(1-2). 1–8. 34 indexed citations
9.
Bitton, Roberto, William D. Figg, David Venzon, et al.. (1995). Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin.. Journal of Clinical Oncology. 13(9). 2223–2229. 29 indexed citations
10.
Bitton, Roberto, William D. Figg, & Eddie Reed. (1995). A Preliminary Risk-Benefit Assessment of Paclitaxel. Drug Safety. 12(3). 196–208. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maya Datt Joshi Breakdown of academic impact, for papers by Zahide Özer Breakdown of academic impact, for papers by Marie-Christine Multon Breakdown of academic impact, for papers by Joël S. Bloch Breakdown of academic impact, for papers by Mizue Inoue Breakdown of academic impact, for papers by A. Takada Breakdown of academic impact, for papers by Shashi Mehta Breakdown of academic impact, for papers by Sheila Zrihan‐Licht Breakdown of academic impact, for papers by Olga Lubman Breakdown of academic impact, for papers by Toshihide Nishibata
Rankless by CCL
2026